Related Experiment Video
Updated: May 11, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines
Yishan Liu1, Xueping Wu, Xiaoran Li
1Department of Urology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Abstract:
Ethidium bromide (EtBr) is an intercalating agent, which binds tightly to mitochondrial DNA (mtDNA) during replication, and so blocks the function of mitochondria. EtBr inserts itself between the stacked bases in double-stranded DNA and specifically inhibits mtDNA transcription and replication by deleting RNA primers required for initiating mtDNA replication. In this study, the authors wanted to examine whether blocking mtDNA replication with EtBr could change the expression of stenmness genes and the expression of the immuneregulator B7-H3 in prostate cancer cell lines in vitro. Both PC-3 and DU145 prostate cancer cell lines were treated with 50 and 500 ng/mL of EtBr for 2 weeks. There was no difference in growth between EtBr-treated and control cells after 1 week. A slightly slower growth was observed for both cell lines during the second week of culture with EtBr compared to controls. After 2 weeks of culture with EtBr both cell lines showed increased expression of the stemness-related genes ABCG2, Oct3/4, Nanog1/Nanogp8, and CD44. Concomitantly, a dose-dependent increase of B7-H3 protein expression in both cell lines was identified and verified by both flow cytometry and immunocytochemistry. In conclusion, blocking mtDNA replication by EtBr induces increased expression of stemness genes, such as Oct3/4, Nanog, CD44, and ABCG2, in addition to the immune regulator B7-H3 in PC-3 and DU145 prostate cancer cell lines. The findings indicate that mitochondrial function may be associated with stemness of cancer cells and/or maintenance of a cancer stem cell phenotype. The finding of increased B7-H3 expression may be associated with the immunosuppression of cancer cells.
Insights
Blocking mitochondrial DNA replication with ethidium bromide (EtBr) increased stemness genes and B7-H3 expression in prostate cancer cells. This suggests a link between mitochondrial function and cancer stem cell phenotypes.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Ethidium bromide (EtBr) is an intercalating agent that inhibits mitochondrial DNA (mtDNA) transcription and replication.
- Mitochondrial dysfunction is increasingly implicated in cancer progression and stemness.
Purpose of the Study:
- To investigate the effect of blocking mtDNA replication using EtBr on stemness gene expression and B7-H3 levels in prostate cancer cell lines.
- To explore the potential association between mitochondrial function and cancer stem cell characteristics.
Main Methods:
- PC-3 and DU145 prostate cancer cell lines were treated with EtBr (50 and 500 ng/mL) for two weeks.
- Cell growth was monitored, and expression of stemness genes (ABCG2, Oct3/4, Nanog, CD44) and B7-H3 protein was assessed using flow cytometry and immunocytochemistry.
Main Results:
- EtBr treatment led to a slight decrease in cell growth during the second week.
- Increased expression of stemness genes (Oct3/4, Nanog, CD44, ABCG2) was observed in EtBr-treated cells.
- A dose-dependent increase in B7-H3 protein expression was detected in both cell lines.
Conclusions:
- Inhibition of mtDNA replication by EtBr upregulates stemness-related genes and the immune regulator B7-H3 in prostate cancer cells.
- Mitochondrial function may play a role in maintaining cancer stem cell phenotypes.
- Elevated B7-H3 expression could contribute to cancer cell-mediated immunosuppression.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

